ArticleJournal of oncology2022

Prognostic Signature, Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma.

Muge Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.